Hasil Pencarian - Jessica L Geiger

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    Acinic Cell Carcinoma of the Salivary Gland with Metastatic Spread to the Pancreas

    Acinic Cell Carcinoma of the Salivary Gland with Metastatic Spread to the Pancreas oleh Jessica L. Geiger, Joaquín J. García, Katharine A.R. Price

    Diterbitkan 2014-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Clinical trials optimizing investigator and self‐collection of buccal cells for RNA yield

    Clinical trials optimizing investigator and self‐collection of buccal cells for RNA yield oleh Jessica L. Geiger, Elizabeth D. Cedars, Yan Zang, Daniel P. Normolle, Hua Li, Jennifer R. Grandis, Sara Centuori, Daniel E. Johnson, Julie E. Bauman

    Diterbitkan 2021-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing

    Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing oleh Thomas Eigentler, Danny Rischin, Michael R Migden, Annette M Lim, Chrysalyne D Schmults, Nikhil I Khushalani, Lara A Dunn, Leonel Hernandez-Aya, Anne Lynn S Chang, Badri Modi, Claas Ulrich, Brian Stein, Jessica L Geiger, Emmanuel Okoye, Melissa Mathias, Jocelyn Booth, Siyu Li, Matthew G Fury

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Outcomes of Post-Operative Treatment with Concurrent Chemoradiotherapy (CRT) in High-Risk Resected Oral Cavity Squamous Cell Carcinoma (OCSCC): A Multi-Institutional Collaboration

    Outcomes of Post-Operative Treatment with Concurrent Chemoradiotherapy (CRT) in High-Risk Resected Oral Cavity Squamous Cell Carcinoma (OCSCC): A Multi-Institutional Collaboration oleh Arslan Babar, Neil M. Woody, Ahmed I. Ghanem, Jillian Tsai, Neal E. Dunlap, Matthew Schymick, Howard Y. Liu, Brian B. Burkey, Eric D. Lamarre, Jamie A. Ku, Joseph Scharpf, Brandon L. Prendes, Nikhil P. Joshi, Jimmy J. Caudell, Farzan Siddiqui, Sandro V. Porceddu, Nancy Lee, Larisa Schwartzman, Shlomo A. Koyfman, David J. Adelstein, Jessica L. Geiger

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    1530 T-cell responses to individualized neoantigen therapy (INT) mRNA-4157 (V940) as monotherapy or in combination with pembrolizumab

    1530 T-cell responses to individualized neoantigen therapy (INT) mRNA-4157 (V940) as monotherapy or in combination with pembrolizumab oleh Wei Zheng, Jing Sun, Jeffrey Weber, Manish R Patel, Brandon Coder, Igor Feldman, Justin F Gainor, Jessica L Geiger, Martin Gutierrez, Joshua Frederick, Celine Robert-Tissot, Robert Meehan, Jack Pollard, Lakshmi Srinivasan, Michelle Brown, Kedar Kirtane, Julie E Bauman, Praveen Aanur, Jeffrey M Clarke, Ricklie A Julian, Aaron J Scott, Moomal Tasneem, Lauren Gerbereux, Andressa Laino, Peijie Hou, Vasudha Sehgal, Hikmat N Daghestani, Howard A Burris

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: